Isabelle van Rycke
Vorstandsvorsitzender bei Upsa Belgium SA
Aktive Positionen von Isabelle van Rycke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Upsa Belgium SA
 Upsa Belgium SA Medical DistributorsDistribution Services UPSA Belgium SA wholesales pharmaceutical products. The private company is based in Etterbeek, Belgium. The CEOs are Isabelle van Rycke, Jun Kuroda. The Belgian company was founded in 2019. | Direktor/Vorstandsmitglied | 01.07.2021 | - |
| Vorstandsvorsitzender | 01.07.2021 | - | |
UPSA SAS
 UPSA SAS Pharmaceuticals: MajorHealth Technology Part of Taisho Pharmaceutical Holdings Co., Ltd., UPSA SAS is a pharmaceutical laboratory that specializes in effervescence, pain treatment, ENT disorders, vitality, digestion, and sleep quality. The company is based in Rueil-Malmaison, France. The CEOs of the French company are Anthony Lallier and Isabelle van Rycke. UPSA was acquired by Taisho Pharmaceutical Co., Ltd. from Bristol Myers Squibb Co. on July 01, 2019 for $1,465.24 million. | Vorstandsvorsitzender | 01.05.2021 | - |
| Vorsitzender | 01.05.2021 | - |
Karriereverlauf von Isabelle van Rycke
Statistik
International
| Belgien | 2 |
| Frankreich | 2 |
Operativ
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sektoral
| Distribution Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Upsa Belgium SA
Upsa Belgium SA Medical DistributorsDistribution Services UPSA Belgium SA wholesales pharmaceutical products. The private company is based in Etterbeek, Belgium. The CEOs are Isabelle van Rycke, Jun Kuroda. The Belgian company was founded in 2019. | Distribution Services |
UPSA SAS
UPSA SAS Pharmaceuticals: MajorHealth Technology Part of Taisho Pharmaceutical Holdings Co., Ltd., UPSA SAS is a pharmaceutical laboratory that specializes in effervescence, pain treatment, ENT disorders, vitality, digestion, and sleep quality. The company is based in Rueil-Malmaison, France. The CEOs of the French company are Anthony Lallier and Isabelle van Rycke. UPSA was acquired by Taisho Pharmaceutical Co., Ltd. from Bristol Myers Squibb Co. on July 01, 2019 for $1,465.24 million. | Health Technology |
- Börse
- Insiders
- Isabelle van Rycke
- Erfahrung
